nference announced a strategic research alliance with Takeda aimed at harnessing artificial intelligence (AI) to optimize patient care in inflammatory bowel disease (IBD), a...
The total number of Hyperfine AI-powered marketing authorizations places the company in a leading position on recently published FDA list.
Hyperfine, the groundbreaking medical device...
CytoReason, a leader in developing computational disease models for predictive insights, announced it secured an aggregated $80 million from OurCrowd, NVIDIA, Pfizer, and Thermo...
Tempus AI, Inc., a leader in artificial intelligence and precision medicine, announced that its multimodal immune profile score (IPS) algorithmic test is now available...
Circle Cardiovascular Imaging, the global leader in AI-driven cardiovascular imaging solutions, announced that Erkan Akyuz has been appointed Chief Executive Officer, effective August 5,...
Mendel AI, a leader in clinical AI for the life sciences industry, announced it has joined NVIDIA Inception, a program that nurtures startups revolutionizing...